What is it about?
This is the first systematic review that integrates the gut microbiome and metabolites in cancer research, showing decreased gut microbiome diversity and short-chain fatty acids with increased amino acids in colorectal cancer patients.
Featured Image
Read the Original
This page is a summary of: A systematic review of the gut microbiome, metabolites, and multi-omics biomarkers across the colorectal cancer care continuum, Beneficial Microbes, January 2017, De Gruyter,
DOI: 10.1163/18762891-bja00026.
You can read the full text:
Contributors
The following have contributed to this page







